Evidence map›Paper›PMID 42007055›Full record

ArticleACS measurement science au2026

Automatic Delineation of Tumor Spheroids in Microscopic Images Using Deep-Learning.

Jens Maus, Janina Nitschke, Pavel Nikulin, Frank Hofheinz, Mareike Barth, Sandy Lemm, Lena Richter, Jens Pietzsch, Anja Braune, Martin Ullrich

Abstract read
In one paragraph

Article in ACS measurement science au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jens MausInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.ORCID https://orcid.org/0000-0002-7195-9927
Janina NitschkeInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Pavel NikulinInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Frank HofheinzInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Mareike BarthInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Sandy LemmInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Lena RichterInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Jens PietzschInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.ORCID https://orcid.org/0000-0002-1610-1493
Anja BrauneInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.
Martin UllrichInstitute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, 01328 Dresden, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumor spheroid growth assays are used to evaluate the potential of cancer therapies in vitro. During such experiments, extensive microscopic image series are generated, which are commonly analyzed using threshold-based delineations. However, due to treatment-induced morphological changes of the spheroids, very time-consuming manual corrections are often required. The goal of our work was the development of an AI-based method for accurate and automated delineation of spheroid growth assays, ultimately reducing the reliance on manual delineation and corrections. Spheroids were grown from mouse pheochromocytoma (MPC) cells and subjected to irradiation with particle-emitting radioligands. Spheroid growth was monitored over 35 days. N = 38090 images, acquired within seven experiments and two studies, were included. Spheroids were delineated with a threshold-based method followed by manual corrections and the resulting delineations served as ground truth for network training and testing. The data were divided into two independent data sets: one for training and internal validation using a 5-fold cross-validation (N = 21567; main data set) and another for final independent testing (N = 16523). The network was developed using the nnU-Net v2 deep-learning (DL) framework. DL-based and manual delineations were compared using the

Indexed as

Artifical IntelligenceCancerConvolutional Neural NetworksDeep-LearningDelineationRadiopharmacological Treatment Response AssaysTumor Spheroid Imaging

Identifiers

PMID42007055
PMCPMC13087938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.